Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-09-22
2023-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training
Data from 25-35 participants will be used to train an algorithm to generate synthetic CT images from MRI scans.
CT scan
Participants receive a CT scan of the head as part of their regular care. A larger part of the head will be scanned than for standard care.
MRI scan
Participants receive an MRI scan, specifically for the purpose of the study.
Testing
Data from remaining participants will be used to test the synthetic CT algorithm, by comparing true CT scans to synthetic CT scans made from MRI.
CT scan
Participants receive a CT scan of the head as part of their regular care. A larger part of the head will be scanned than for standard care.
MRI scan
Participants receive an MRI scan, specifically for the purpose of the study.
Synthetic CT scan
Synthetic CT scans will be generated from MRI scans, using the trained machine learning algorithm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT scan
Participants receive a CT scan of the head as part of their regular care. A larger part of the head will be scanned than for standard care.
MRI scan
Participants receive an MRI scan, specifically for the purpose of the study.
Synthetic CT scan
Synthetic CT scans will be generated from MRI scans, using the trained machine learning algorithm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years or older.
* Referred for CT scan of the mastoid, sinonasal complex or face.
Exclusion Criteria
* Contra-indications for MRI or CT.
* Unwillingness to be informed about possibly clinically relevant, incidental findings from the MRI examination.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MRIguidance B.V.
INDUSTRY
Amsterdam UMC, location VUmc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Merkus
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Merkus, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC, location VUmc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam University Medical Center
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL80426.029.22
Identifier Type: REGISTRY
Identifier Source: secondary_id
2022.0234
Identifier Type: -
Identifier Source: org_study_id